Genentech

PERJETA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Genentech

Perjeta HCPCS:

J9306

HCPCS Code Descriptor:

Injection, pertuzumab, 1 mg

Category:

J Code

Perjeta NDCs:

50242-0145-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Perjeta CPT Codes:

-96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

-96415 - Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

-96417 - Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Perjeta:

PERJETA is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9306 is aligned to the drug PERJETA.

ACCESS PRICING AND MORE BY REGISTERING

J9306 Added Date:

January 1, 2014

J9306 Effective Date:

January 1, 2014

J9306 Termination Date:

HCPCS Active

Perjeta billing and coding information can be found through Genentech at the link below:
Perjeta patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
PERJETA prescribing information can be found at the link below:
Information regarding PERJETA’s side effects can be found at MedlinePlus